Version 1
: Received: 5 November 2023 / Approved: 6 November 2023 / Online: 7 November 2023 (11:39:43 CET)
How to cite:
Niculescu, V. Introduction to Evolutionary Cancer Cell Biology (Eccb) and Ancestral Cancer Genomics. Preprints2023, 2023110383. https://doi.org/10.20944/preprints202311.0383.v1
Niculescu, V. Introduction to Evolutionary Cancer Cell Biology (Eccb) and Ancestral Cancer Genomics. Preprints 2023, 2023110383. https://doi.org/10.20944/preprints202311.0383.v1
Niculescu, V. Introduction to Evolutionary Cancer Cell Biology (Eccb) and Ancestral Cancer Genomics. Preprints2023, 2023110383. https://doi.org/10.20944/preprints202311.0383.v1
APA Style
Niculescu, V. (2023). Introduction to Evolutionary Cancer Cell Biology (Eccb) and Ancestral Cancer Genomics. Preprints. https://doi.org/10.20944/preprints202311.0383.v1
Chicago/Turabian Style
Niculescu, V. 2023 "Introduction to Evolutionary Cancer Cell Biology (Eccb) and Ancestral Cancer Genomics" Preprints. https://doi.org/10.20944/preprints202311.0383.v1
Abstract
Cancer is a complex and devastating disease that has engaged scientists and researchers for decades. Despite tremendous efforts, previous hypotheses about cancer development have not achieved significant breakthroughs. Evolutionary Cancer Cell Biology (ECCB) is a novel and emerging branch of oncological science that provides an evolutionary perspective on the origin of cancer. It reveals that the cancer genome evolved hundreds of millions of years ago, long before multicellular organisms such as metazoans and humans emerged. ECCB aims to unify all evolutionary insights, hypotheses, and theories into a cohesive framework. It investigates the intricate relationship between cancer genomics and ancient pre-metazoan genes that emerge when normal cells transform into cancer cells. It challenges the conventional wisdom of cancer research by suggesting that cancer could arise through intrinsic cellular mechanisms without genetic alterations and mutations. Furthermore, it postulates that somatic mutations are only secondary, downstream events in the process of oncogenesis.
Medicine and Pharmacology, Oncology and Oncogenics
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
